Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionVident Advisory, LLC
Latest Disclosed Ownership98,876 shares
Latest Disclosed Value $ 10,151,633
Vident Advisory, LLC reports 15.49% increase in ownership of ABL / Abbott Laboratories

On May 14, 2026 - Vident Advisory, LLC filed a 13F-HR form disclosing ownership of 98,876 shares of Abbott Laboratories (DE:ABL) valued at $8,782,166 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 85,614 shares of Abbott Laboratories. This represents a change in shares of 15.49% during the quarter. The current value of the position is $7,437,453 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 98,876 13,262 15.49 10,152 -5.36 0.0864
2026-02-18 2025-12-31 13F ABBOTT LABS COM 002824100 85,614 6,005 7.54 10,727 0.60 0.0977
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 79,609 14,671 22.59 10,663 20.72 0.1019
2025-08-14 2025-06-30 13F ABBOTT LABS COM 002824100 64,938 10,141 18.51 8,832 21.50 0.0992
2025-05-15 2025-03-31 13F ABBOTT LABS COM 002824100 54,797 19,898 57.02 7,269 84.17 0.1062
2025-02-14 2024-12-31 13F ABBOTT LABS COM 002824100 34,899 8,098 30.22 3,948 29.20 0.0692
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 26,801 -23,688 -46.92 3,056 -41.77 0.0769
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 50,489 25,823 104.69 5,246 87.16 0.1449
2024-05-14 2024-03-31 13F ABBOTT LABS COM 002824100 24,666 -180,951 -88.00 2,804 -87.61 0.0584
2024-02-14 2023-12-31 13F ABBOTT LABS COM 002824100 205,617 19,176 10.29 22,632 25.34 0.5688
2024-02-21 2023-09-30 13F/A-01 ABBOTT LABS COM 002824100 186,441 186,441 18,057 0.5594
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 186,441 186,441 18,057 0.4504
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.